MLOAX | MLPLX | MLOAX / MLPLX | |
Total Expense Ratio | 1.25 | 8.06 | 16% |
Annual Report Gross Expense Ratio | 1.65 | 8.06 | 20% |
Fund Existence | 11 years | 13 years | - |
Gain YTD | 4.951 | 4.039 | 123% |
Front Load | 5% | 6% | 82% |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 117M | 305M | 38% |
Annual Yield % from dividends | 4.97 | 5.32 | 93% |
Returns for 1 year | 6.66 | 27.34 | 24% |
Returns for 3 years | 31.75 | 112.48 | 28% |
Returns for 5 years | 129.80 | 344.88 | 38% |
Returns for 10 years | 30.97 | 29.98 | 103% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPAX | 19.06 | -0.09 | -0.47% |
Saratoga Health & Biotechnology A | |||
DEMAX | 24.36 | -0.29 | -1.18% |
Macquarie Emerging Markets A | |||
IOAPX | 27.86 | -0.35 | -1.24% |
Invesco Main Street All Cap R6 | |||
PICEX | 7.13 | -0.09 | -1.25% |
Virtus SGA Emerging Markets Equity C | |||
AIGIX | 21.39 | -0.30 | -1.38% |
Alger International Opportunities I |